Medical Health & Life Science Research News

Top trends in vaccine market published by leading research firm

Medical Market Research

The vaccines market is projected to reach USD 49.27 billion by 2022 from USD 34.30 billion in 2017, vaccines market at a CAGR of 7.5% Grow During Forecast Period.

- Advertising -

North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period.

The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.

- Advertising -

Access report@ www.rnrmarketresearch.com/contacts…mple?rname=110437

Factors such as rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing investments by companies are driving the vaccine market.

By technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. 

Based on the end user, the vaccines market is segmented into pediatrics and adults. The adult segment is expected to register the highest CAGR during the forecast period.

Factors like the increasing investments by companies for the development of new adult vaccines and government initiatives for immunization are driving the growth of this segment.

Based on type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent segment is expected to dominate this market with the largest share due to increasing investments by companies to develop new vaccines.

Inquire about report at www.rnrmarketresearch.com/contacts…ying?rname=110437

Target Audience of this Vaccine market is follow:

  • Manufacturers and suppliers of vaccines
  • Research and development companies
  • Medical research laboratories
  • Academic medical centers and universities
  • Research and consulting firms
  • Venture capital firms 

#Top 25 Key players Analyzed included in Vaccine market report are - Pfizer, Inc., Glaxosmithkline PLC., Merck & Co., Inc., Sanofi Pasteur SA, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC, Astellas Pharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Protein Science Corporation, Daiichi Sankyo Company, Limited, Abbott Laboratories, Panacea Biotec, Paxvax, Inc., Zydus Cadila, Green Cross Corporation, Valneva Se, Indian Immunologicals Limited, Incepta Vaccine Ltd., Sinovac Biotech Ltd., Vbi Vaccines Inc., Pt Bio Farma (Persero)

North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period.

The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.

Access report at @ www.rnrmarketresearch.com/contacts…hase?rname=110437 

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall vaccines market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies.

 

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.